News

Why Research Matters: Therapeutic Oral Cancer Epigenetic Regulation with Dr. Manish Bais, Associate Professor of Translational Dental Medicine

In our new research series, “Why Research Matters,” we are speaking with GSDM faculty about what sparked their research interests, what they're working on now, and how they hope their findings will lead to meaningful changes in oral healthcare treatment. In Dr. Manish Bais’, associate professor of translational dental medicine, recent research, he and a team of fellow researchers are looking into epigenetic regulation-based treatment for oral squamous cell carcinoma (OSCC), an emerging alternative to immunotherapy that targets and reverses poor gene expression patterns. More

The 2025 Boston Head & Neck Cancer Symposium Highlights the Molecular and Cellular Mechanisms Underlying Cancer Complexity, Technological Advancements, Innovative Therapeutic Approaches, and Patient Insight

The seventh installment of the Boston Head and Neck Cancer Symposium was held on Thursday, October 9. The symposium was co-hosted by Boston University, the Dana-Farber Cancer Institute, and Mass General Brigham/Mass Eye and Ear. More